| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Corrigendum to “SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo” [Cancer Lett. 351 (2014) 143–50]
|
Wang, Lu
|
|
|
486 |
C |
p. 71-72
|
artikel
|
| 2 |
Disulfiram potentiates the anticancer effect of cisplatin in atypical teratoid/rhabdoid tumors (AT/RT)
|
Jangra, Anshika
|
|
|
486 |
C |
p. 38-45
|
artikel
|
| 3 |
Editorial Board
|
|
|
|
486 |
C |
p. ii
|
artikel
|
| 4 |
Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs
|
Chinnappan, Mahendran
|
|
|
486 |
C |
p. 18-28
|
artikel
|
| 5 |
Hypoxia and cancer related pathology
|
Xiong, Qiuxia
|
|
|
486 |
C |
p. 1-7
|
artikel
|
| 6 |
LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 and phosphorylation of AKT in EGFR-mutant lung cancers
|
Chen, Chen
|
|
|
486 |
C |
p. 58-70
|
artikel
|
| 7 |
Targeting NUPR1 with the small compound ZZW-115 is an efficient strategy to treat hepatocellular carcinoma
|
Lan, Wenjun
|
|
|
486 |
C |
p. 8-17
|
artikel
|
| 8 |
Targeting the IRE1-XBP1 axis to overcome endocrine resistance in breast cancer: Opportunities and challenges
|
Barua, David
|
|
|
486 |
C |
p. 29-37
|
artikel
|
| 9 |
The novel dual BET/HDAC inhibitor TW09 mediates cell death by mitochondrial apoptosis in rhabdomyosarcoma cells
|
Laszig, Stephanie
|
|
|
486 |
C |
p. 46-57
|
artikel
|
Tijdschrift beschrijving